You are here

Horizon Pharma

Amgen's new Horizon products bolster top line despite continued Tepezza struggles

Fierce Pharma

Fri, 05/3/24 - 11:23 am

Roche, Horizon lead way for pharma reputation among rare disease patient groups

Medical Marketing and Media

Wed, 08/23/23 - 05:49 pm

Large pharmas probe takeover of Horizon Therapeutics

BioPharma Dive

Wed, 11/30/22 - 10:58 am

Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs

Fierce Pharma

Mon, 08/29/22 - 10:51 am

drug manufacturing

In a quiet year for takeouts, who was buying?

EP Vantage

Fri, 01/28/22 - 09:54 am

Jazz Pharmaceuticals

Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients

Fierce Pharma

Tue, 01/19/21 - 10:44 am

thyroid eye disease

FDA in-house review spotlights an issue with one of Horizon's endpoints but notes efficacy for lead drug

Endpoints

Thu, 12/12/19 - 11:01 am

clinical trials

thyroid eye disease

Horizon Pharma’s Thyroid Eye Disease Treatment Could Become a Blockbuster, Analyst Predicts

BioSpace

Mon, 04/29/19 - 09:37 pm

thyroid eye disease

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs

Yahoo/Benzinga

Mon, 04/22/19 - 10:34 am

Concert Pharmaceuticals

Edwards Lifesciences

Precision Biosciences

Boston Scientific

Bristol-Myers Squibb

Seattle Genetics

After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application

Endpoints

Fri, 03/1/19 - 09:29 am

thyroid eye disease

Genentech, Horizon Earn Spots on List of ‘Companies That Care’

BioSpace

Sat, 07/28/18 - 12:39 pm

Horizon Pharma Receives Two Additional Patents on Ravicti

CP Wire

Tue, 05/8/18 - 10:21 am

Horizon Pharma Receives Two Additional Patents on Ravicti

Tue, 05/8/18 - 09:58 am

Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo

Forbes

Thu, 03/15/18 - 09:33 pm

Specialty pharmacy scrutiny hits again with state's focus on Horizon meds

Fierce Pharma

Sat, 12/9/17 - 02:26 pm

specialty pharmacies

Express Scripts

Valeant Pharmaceuticals

Krystexxa shows signs of life as Horizon keeps pushing sales force expansion

Fierce Pharma

Wed, 10/11/17 - 11:20 am

Horizon CEO Tim Walbert knows patients because he is one

Medical Marketing and Media

Wed, 08/23/17 - 11:39 am

autoimmune disease

Horizon dives into eye treatments with River Visions acquisition

BioPharma Dive

Sun, 05/14/17 - 12:56 pm

Horizon Pharma buys River Vision and its fast-tracked eye med for $145M

Fierce Biotech

Mon, 05/8/17 - 10:07 pm

thyroid eye disease

Tapping into the rare disease market

BioPharma Dive

Fri, 03/10/17 - 09:00 pm

Pages